PTU - Polskie Towarzystwo Urologiczne
home page
current numbers
archival numbers
list of articles:
list przewodni/covering letter
editor
Scientific Committee
publisher
subscription
advertising
important links

THE LEVEL OF HISTOLOGICAL MALIGNANCY OF TRANSCELLULAR CARCINOMA IN THE URINARY BLADDER COMPARED WITH THE BLOOD GROUP ANTIGENS AND THE AGE OF PATIENTS
Article published in Urologia Polska 1988/41/3.

authors

Wojciech Szewczyk, Andrzej Prajsner, Adam Szkodny
Z I Katedry i Kliniki Urologii ¦l±skiej Akademii Medycznej im. Ludwika
Waryñskiego w Katowicach Kierownik Kliniki: prof. dr hab. med. A. Szkodny

summary

The authors made a retrospective analysis of a group of 436 patients with transcellular carcinoma in the urinary bladder. It was found that the percentage of sick persons with respective blood groups in Comparison with healthy persons was similar. No statistically significant relationship was found between the blood group antigen and the level of histological malignancy of the neoplasm. The authors found, however, that most fre±uently, the transcellular carcinoma of the urinary bladder occurs among persons aged from 51 to 80 years (86.5% of all neoplasms). The older the patients were, the more malignant was the neoplasm. The highest degree of neoplasm malignancy was found in the age group of 71?80 years.

references

  1. 1. Bishop M.C: Blood group antigens and bladder cancer. Brit. Med. J., 1982, 284, 1424. ? 2. Coon J.S., Weinstein R.S.: Varia:bility in the expression of the O/H) antigen in human transitional epithelium. J. Urol., 1981, 125, 301. ? 3. Cowan W.K.: Blood group antigens on human gastrointestinal carcinoma cell. Brit. J. Cancer, 1962, 16, 535. ? 4. Fitzpatric JM., Reda M.: Bladder carcinoma in patients 40 years old or less. J. Urol., 1986, 135, 53. ? 5. Hammou J.C., Fella C, Vacant J., Maiolini R., Masseyeff R.: Improvement of the demonstration of A, B, H surface antigens in bladder tumors by a simple immunofluorescence techni±ue. J. Urol., 1982, 128, 1183. ? 6. Paterson P.P.: A B H secretor status in patients with bladder tumours. Urol. Res., 1976, 4, 147. ? 7. Sprinivas V., Orihuela E., Lloyd K.O., Old L.J., Whit­more W.P. Jr.: Estimation of A B O/H) isoantigens expresion in bladder tumors. J. Urol., 1985, 133, 25. ? 8. Sprinivas V., Hansen P.A., Kiruluta H.G.: Single cell suspension of human bladder mucosa: possible use in quantitating A B O/H/ iso­antigens in transitional cell carcinoma of bladder. Urology, 1982, 20, 608. ? 9. Srini-vas V., Kiruluta H.G.: A B O/H/ isoantigens in bladder tumors: a new techni±ue of quantitative analysis. J. Urol., 1984, 131, 254. ? 10. Srinivas V., Ali Khan S., Hoisington S., Varma A., Gonder M.J.: Relationship of blood groups and bladder cancer. J. Urol., 1986, 135, 50.
  2. 11. Zieliñski J: Onkologia urologiczna. PZWL, Warszawa, 1986, 132. ? 12. Zincke H.: Symposium on advances in the management of urothelial cancer. The Urologic Clinics of North America. W. B. Saunders, Philadelphia, 1984, 4.